In this study of more than 5000 patients with bipolar disorder, we found an association between CYP2C19 metabolic phenotypes and a manic episode within 3 months of starting treatment with either sertraline or the tricyclic antidepressants amitriptyline and clomipramine. The gene discussed is CYP2C19; the disease is bipolar disorder.